A Randomized, Double-Blind, Multicenter, Parallel Pilot Clinical Trial to Study the Efficay of a Treatment of Lactulose + Vitamin D + Calcium 0.5 g Concurrently Controlled With a Standard Treatment (Vit D + Calcium) in Bone Mass Preservation Among Postmenopausal Women
Sponsor study identifier
interventional
40
1 country
3
Study Start
January 2003
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
Not reported
Date not reportedThis is a randomized, double-blind, multicentre, parallel pilot clinical trial to study the efficacy of a treatment of lactulose 15 ml + vitamin D 400 U + calcium 0.5 g compared to lactulose placebo 15 ml + vitamin D 400 U + calcium 1 g in bone mass preservation among postmenopausal women.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 2003
Date type not reportedThis date has not been verified as actual or estimated.
September 9, 2005
Actual (reported)September 12, 2005
Actual (reported)bone mass preservation by bone densitometry values in 1 year period
evolution of bone remodelling parameters
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Site 1
Barcelona, Spain
Site 2
Barcelona, Spain
Site 3
Barcelona, Spain
Global Clinical Director Solvay
Solvay Pharmaceuticals
First Submitted
September 9, 2005
First Posted
September 12, 2005
Study Start
January 2003
Date type not reportedThis date has not been verified as actual or estimated.
Last Updated
January 30, 2009
Record last verified: 2009-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved:
Contact the study team to confirm eligibility.